Mondelez posted its fourth quarter earnings that missed analysts' expectations, even as revenue surpassed forecasts.
The confectionary giant’s earnings came in at $0.71 a share, below the $0.7187 expected by analysts polled by Investing.com. Revenue of $7.66 billion was above analysts’ expectations of $7.58 billion.
Adjusted operating income of the North America business for the full year 2021 was $1.59 billion, down -10% from a year ago. Sales were up +1.8%.
Looking ahead, Mondelez expects 2022 growth rates to be in line with its long-term objectives of 3% organic revenue and high single-digit adjusted earnings per share growth with free cash topping $3 billion. However, the company mentioned that its outlook was issued “in the context of greater-than-usual volatility as a result of COVID-19”.
CFO Luca Zaramella said that inflationary pressures will persist in 2022.
The 10-day moving average for MDLZ crossed bearishly below the 50-day moving average on October 11, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on October 23, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on MDLZ as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for MDLZ turned negative on September 18, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .
MDLZ moved below its 50-day moving average on October 03, 2024 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDLZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for MDLZ entered a downward trend on October 23, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MDLZ's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where MDLZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDLZ advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .
MDLZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.315) is normal, around the industry mean (6.522). P/E Ratio (19.268) is within average values for comparable stocks, (26.887). Projected Growth (PEG Ratio) (2.392) is also within normal values, averaging (2.471). Dividend Yield (0.024) settles around the average of (0.043) among similar stocks. P/S Ratio (2.653) is also within normal values, averaging (66.610).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MDLZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of packaged food products
Industry FoodSpecialtyCandy